✦ LIBER ✦

Pharmacoeconomic Analysis of Capecitabine versus 5-Fluorouracil/Leucovorin as Adjuvant Therapy for Stage III Colon Cancer in Taiwan

✍ Scribed by Tzu-Chi Hsu; Hong-Hwa Chen; Ming-Chin Yang; Hwei-Ming Wang; Jye-Hann Chuang; Shu-Wen Jao; Hsin-Chieh Chiang; Chung-Yu Wen; Jen-Hao Tseng; Li-Tzong Chen

Book ID: 119308751
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 395 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.01.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-Fluorouracil/leucovorin versus capecit

5-Fluorouracil/leucovorin versus capecitabine in patients with stage III colon cancer

✍ Jean-François Seitz 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 458 KB

CN2 PHARMACOECONOMIC ANALYSIS OF CAPECIT

CN2 PHARMACOECONOMIC ANALYSIS OF CAPECITABINE IN ADJUVANT TREATMENT OF STAGE III COLON CANCER IN TAIWAN

✍ TC Hsu; HH Chen; LT Chen; CR Changchien; MC Liu; HM Wang; L Yang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Adjuvant capecitabine is at least as eff

Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer

✍ C. Lamberti; T. Sauerbruch; A Glasmacher 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Cost-effectiveness analysis of oxaliplat

Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US

✍ Samuel Aballéa; Jeremy V.M. Chancellor; Maria Raikou; Michael F. Drummond; Milto 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

PCN113 PHARMACOECONOMIC ANALYSIS OF CAPE

PCN113 PHARMACOECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS 5-FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE FIRST LINE TREATMENT OF METASTASIS COLORECTAL CANCER IN TAIWAN

✍ HH Chen; CS Chang; LT Chen; WT Chen; TC Hsu; JY Wang; CY Wen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

1089 Improved safety of capecitabine vs

1089 Improved safety of capecitabine vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT phase III study)

✍ Nowacki, M.; Kröning, H.; Cervantes, A.; Husseini, F.; McKendrick, J.; Schuller, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB